IP Verse

Hamm & Wittkopp patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Hamm & Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm & Wittkopp

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 23, 2025	BETAPHARM ARZNEIMITTEL
EP3242666	Methods Of Treating Conditions Related To The S1P1 Receptor	ARENA PHARMACEUTICALS	Jul 15, 2025	SYNTHON
EP3226841	Anticancer Compositions	ARAGON PHARMACEUTICALS	Jul 7, 2025	HAMM & WITTKOPP
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 1, 2025	STADA ARZNEIMITTEL
EP4097091	Solid State Forms Of Mavacamten And Process For Preparation Thereof	ASSIA CHEMICAL INDUSTRIES	Jun 18, 2025	HAMM & WITTKOPP
EP4084779	Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-Phenylurea	DECIPHERA PHARMACEUTICALS	May 28, 2025	ALFRED E TIEFENBACHER
EP3801459	Methods Of Treating Conditions Related To The S1P1 Receptor	ARENA PHARMACEUTICALS	May 7, 2025	SYNTHON
EP3439662	Liquid Formulations Of (S)-N-(5-((R)-2-(2,5-Difluorophenyl)-Pyrrolidin-1-Yl)-Pyrazolo[1,5-A]Pyrimidin-3-Yl)-3-Hydroxypyrrolidine-1-Carboxamide	LOXO ONCOLOGY	Apr 11, 2025	SYNTHON
EP2818163	Composition For Nasal Application With Improved Stability	MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT	Mar 20, 2025	HAMM & WITTKOPP
EP4005555	Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations	JANSSEN PHARMACEUTICA	Feb 17, 2025	HAMM & WITTKOPP

Top companies who are the clients of Hamm & Wittkopp